Turmeric (Curcumin)

herb Verified

Specifically for Schizophrenia

0% effective

0 votes
0 up • 0 down

Why it works for Schizophrenia:

Curcumin (the active polyphenol in turmeric) has plausible mechanisms and several small randomized add-on trials showing some benefit—mostly for negative symptoms and cognition when used alongside antipsychotics—but the evidence is preliminary. It is not a proven replacement for antipsychotic therapy and should only be used under medical supervision because of interactions and safety issues (bleeding risk, rare liver injury, effects on other drugs).

Mechanistic reasons (why researchers think it could help):

Anti-inflammatory effects. Neuroinflammation is implicated in schizophrenia pathophysiology; curcumin reduces pro-inflammatory cytokines (e.g., IL-6, TNF-α) in preclinical and clinical work, which could ameliorate inflammation-driven symptoms. MDPI
Antioxidant / neuroprotective actions. Curcumin scavenges reactive oxygen species and modulates oxidative-stress pathways that are altered in schizophrenia. MDPI
Modulation of neurotrophic factors (BDNF) and synaptic plasticity. Several trials and preclinical studies report curcumin increases BDNF or downstream signaling, a pathway tied to cognition and negative symptoms. ScienceDirect
Multi-target (neurotransmitter / epigenetic) effects. Curcumin has modest effects on multiple neurotransmitter systems and epigenetic regulators — a “multi-target” profile that could theoretically help heterogeneous schizophrenia symptoms. SAGE Journals

Summary: mechanistic lab and early human biomarker data provide plausible reasons curcumin could improve cognition and negative symptoms in schizophrenia, but mechanisms are complex and not specific (curcumin is pleiotropic). MDPI

How to use for Schizophrenia:

Clinical trials used these regimens (examples):

3,000 mg/day oral curcumin (plain curcumin) for 24 weeks used as an add-on to antipsychotics in a randomized, double-blind trial that reported improvement in negative symptoms vs placebo. (Patients continued their usual antipsychotic medication.) Network of Care
160 mg/day nanocurcumin (a nano-formulation) for 16 weeks as an add-on to antipsychotics in patients with predominant negative symptoms; this trial reported benefit on negative symptoms. Nano-formulations are designed to improve curcumin’s brain bioavailability. Europe PMC
300 mg/day (small pilot) in an 8-week pilot study (add-on) which reported cognitive improvements and reductions in IL-6 in a very small sample. Other pilot trials have used similar low fixed doses for short durations. MDPI

Typical patterns across trials:

Used as adjunctive therapy — curcumin has been trialed in combination with standard antipsychotics, not as monotherapy. Network of Care
Treatment durations in trials ranged from 8 weeks up to 24 weeks (most significant results reported after several months in the larger trials). MDPI
Formulation matters. Plain curcumin has poor oral bioavailability; many studies used either high milligram doses (grams per day) of standard curcumin or enhanced-bioavailability formulations (nanocurcumin, phytosome, curcumin+piperine) to reach therapeutic levels in the brain. Reviews emphasize that choosing a formulation with proved pharmacokinetics is important. MDPI

Practical (research-based) summary you could discuss with a clinician:

If following published trials, curcumin was given in addition to antipsychotics (do not stop existing medication). Typical additive regimens: ~160 mg/day (nanocurcumin) or ~3000 mg/day (standard curcumin) depending on formulation and trial. Treatment was continued for several months in trials. Europe PMC

Scientific Evidence for Schizophrenia:

Randomized clinical trials (examples)

Miodownik et al., Clin Neuropharmacol. 2019 — “Curcumin as add-on to antipsychotic treatment in patients with chronic schizophrenia” (randomized, double-blind, placebo-controlled; ~38 patients; 3 g/day curcumin for 24 weeks; improvement in total PANSS and negative subscale reported). Network of Care
Hosseininasab et al., J Clin Psychopharmacol. 2021 — “Nanocurcumin as an add-on to antipsychotic drugs for treatment of negative symptoms…” (randomized, double-blind, placebo-controlled; 160 mg/day nano-curcumin for 16 weeks; reported improvement of negative symptoms). Europe PMC
Wynn et al. (pilot) — an 8-week randomized, double-blind study investigating curcumin’s effect on BDNF and cognition in schizophrenia (small sample; some cognitive/biomarker signals reported). (See the trial registry / publication references.) Europe PMC
ClinicalTrials.gov records (trial registrations / study details):

NCT02298985 (Curcumin added to antipsychotic treatment — linked to the Clin Neuropharmacol trial). ICHGCP
NCT02476708 (pilot trial of curcumin on cognition in schizophrenia). ClinicalTrials
NCT02104752 (curcumin nanoparticles to improve cognitive dysfunction — study record). ClinicalTrials

Systematic reviews / narrative reviews / mechanistic reviews

“Role of Curcumin in the Management of Schizophrenia: A Narrative Review” — summarizes trials, mechanisms, and the limitations of existing studies. SAGE Journals
MDPI review — “An Update on the Exploratory Use of Curcumin in Neuropsychiatric Disorders” (Antioxidants) — overview of multiple psychiatric trials, bioavailability issues, and the need for better RCTs. MDPI
Recent reviews/meta-reviews on turmeric/curcumin and neuroinflammation/cognition — place schizophrenia work in context and emphasize small sample sizes and variable formulations. ScienceDirect

Specific Warnings for Schizophrenia:

Curcumin/turmeric supplements are often safe at culinary doses, but supplements (especially high doses or enhanced-bioavailability formulas) carry risks. Key warnings shown in regulatory/clinical sources:

Bleeding risk / interaction with anticoagulants and antiplatelets. Curcumin can inhibit platelet aggregation and may increase bleeding when taken with warfarin, clopidogrel, aspirin, or direct oral anticoagulants. People on blood thinners must consult their prescriber and get monitoring (e.g., INR for warfarin). Drugs.com
Liver injury (rare but reported). Cases of liver injury have been reported with concentrated curcumin supplements and with piperine-enhanced preparations. Stop and seek care if symptoms of liver injury occur (jaundice, dark urine, severe nausea). Regulatory bodies have issued advisories. Medical News Today
Drug interactions via drug-metabolism enzymes / transplant drugs. Case reports exist (e.g., possible interaction with calcineurin inhibitors like cyclosporine) and curcumin can affect drug metabolism enzymes; transplant patients and those on immunosuppressants need extreme caution. Health
Pregnancy / breastfeeding. Supplements are not recommended in pregnancy — high doses may not be safe. NCCIH
Gastrointestinal side effects. Nausea, diarrhea, dyspepsia are the common adverse events reported in several trials. Higher doses increase GI effects. WebMD
Iron-binding / potential worsening of iron deficiency. Curcumin can reduce iron absorption and is not advised in iron-deficiency without monitoring. MedicineNet
Do not stop/replace antipsychotics. All trials used curcumin as an adjunct to antipsychotics — there is no evidence that curcumin alone controls psychosis. Abruptly stopping antipsychotics is unsafe. Network of Care

Back to Schizophrenia

General Information (All Ailments)

Note: You are viewing ailment-specific information above. This section shows the general remedy information for all conditions.

What It Is

Turmeric is a yellow-orange culinary spice derived from the root of Curcuma longa, a plant in the ginger family. Its best-studied active component is curcumin, a polyphenol responsible for many of its biological effects. Supplements may contain turmeric powder, curcumin extract (standardized to ~95% curcuminoids), or curcumin combined with absorption enhancers like piperine (from black pepper) or formulated as nanoparticles/phytosomes to increase bioavailability.

How It Works

Curcumin is not “one mechanism” but influences multiple biological pathways. The major known actions include:

• Anti-inflammatory action – It inhibits NF-κB and COX-2 signaling pathways, which are core drivers of chronic inflammation.

• Antioxidant action – Curcumin directly scavenges reactive oxygen species and up-regulates endogenous antioxidant enzymes (e.g., SOD, catalase, glutathione-related enzymes).

• Immune modulation – It shifts immune activity away from excessive pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6).

• Metabolic & vascular effects – Curcumin improves endothelial function, reduces oxidative lipid damage, and may improve insulin sensitivity in some settings.

• Cellular signaling in degeneration & repair – Curcumin can influence apoptosis and autophagy pathways, and has been studied for effects on joint cartilage, neuroinflammation, and even cancer cell biology (as an adjunct, not a primary therapy).

These effects are multi-target and generally modulatory, not extreme or drug-like in strength when taken in typical supplemental doses.

Why It’s Important

Curcumin is studied because chronic low-grade inflammation and oxidative stress are common final pathways in many conditions considered “diseases of aging” — such as osteoarthritis, metabolic syndrome, atherosclerosis, neurodegeneration, and some autoimmune states. By acting upstream on inflammation and oxidative signaling, curcumin is explored for:

• Relief of joint pain and stiffness in osteoarthritis

• Support of cardiovascular health markers

• Improvement of glycemic and lipid parameters in metabolic disorders

• Adjunctive support in conditions with chronic inflammation (research-phase, not curative)

Its importance is less “this cures X” and more “this reliably pushes systems in a protective direction when used correctly, consistently, and with proper delivery”.

Considerations

Bioavailability is low in raw spice form. Most benefit in trials comes from concentrated extracts or specialized delivery forms. Taking turmeric powder in food has culinary and mild physiologic value but is not equivalent to studied extracts.

Drug interactions matter. Curcumin can affect platelet function and interact with anticoagulants/antiplatelets. It may raise levels of certain drugs by modulating liver enzymes or p-glycoprotein.

Dose is not trivial. Effective studied doses often range from ~500–1000 mg/day of standardized curcumin extract (not turmeric powder). Higher is not necessarily better; tolerability and interactions cap the useful range.

GI effects are common. Nausea, bloating, or loose stools can occur, especially at higher doses or on an empty stomach.

Cancer context caution. While there is mechanistic and adjunctive interest in oncology, self-medication in place of evidence-based care is unsafe. In some phases of treatment or with certain agents, antioxidants/anti-inflammatories can theoretically blunt desired therapeutic stress responses.

Pregnancy and surgery contexts. Use is commonly paused prior to surgery due to bleeding-risk concerns. Data in pregnancy/breastfeeding is incomplete; medical guidance is advised.

Helps with these conditions

Turmeric (Curcumin) is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.

Crohn's Disease 0% effective

Stomach Ulcers 0% effective

Flu 0% effective

COVID-19 0% effective

Arthritis 0% effective

Back Pain 0% effective

Conditions

Total Votes

242

Studies

Avg. Effectiveness

Detailed Information by Condition

Crohn's Disease

0% effective

Anti-inflammatory Action: Curcumin inhibits nuclear factor-kappa B (NF-κB), a protein complex that plays a central role in regulating the immune respo...

0 votes Updated 2 months ago 3 studies cited

Browse by Category

Navigation

Account

Listening...